<<BACK

Surgical Rounds - March 2007

Accuracy of Lucid's in vivo Confocal Imaging to be Evaluated for Pigmented Lesion Diagnosis Under NCI Grant

Lucid, Inc. has received a $1.9 million, 3-year grant from the National Institute of Health's (NIH) National Cancer Institute (NCI) to perform a large clinical study to evaluate the efficacy of its VivaScope® in vivo confocal microscopy technology for the diagnosis of pigmented lesions.